Potassium Ion

Potassium Ion

SCHEMBL27822

CCCCCCCCCCCCCCCCCCOP(=O)([O-])[O-].[K+].[K+]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 known ✓ P30556 1/20 0.56
LPAR3 Q9UBY5 8/20 0.59
LPAR2 Q9HBW0 6/20 0.59
LPAR1 Q92633 3/20 0.59
AKT1 P31749 2/20 0.56
CDC25A P30304 2/20 0.56
LMNA P02545 1/20 0.56
ESR1 P03372 1/20 0.56
ADORA3 P0DMS8 1/20 0.56
ADRA1A P35348 1/20 0.56
KCNH2 Q12809 1/20 0.56
CYP3A4 P08684 1/20 0.50
RECQL P46063 2/20 0.47
GLA P06280 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
EPHX2 P34913 1/20 0.47
BLM P54132 1/20 0.47
TERT O14746 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Potassium Ion SCHEMBL3392001 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Potassium Ion SCHEMBL3411903 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Potassium Ion SCHEMBL122618 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Hexadecyl Dihydrogen Phosphate SCHEMBL61626 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Potassium Ion SCHEMBL3851846 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Potassium Ion SCHEMBL11137453 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Potassium Ion SCHEMBL3409563 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Phosphoric Acid Monotetradecyl Ester SCHEMBL3094298 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Potassium Ion SCHEMBL8340229 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A
Potassium Ion SCHEMBL29433163 1.00 LPAR3 (0.59) LPAR3LPAR2LPAR1AKT1CDC25A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 248 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119121429-A Textile auxiliary for producing weather-resistant polyester staple fibers 太仓市隆纺油剂有限公司 2024-12-13 CN claimed
CN-115443185-A Product recovery method and device used in preparation and use processes of wastewater treatment agent 兰州兰石中科纳米科技有限公司 2022-12-06 CN claimed
CN-112853570-A Metallic yarn composite fabric and preparation method thereof 嘉兴市昊鸣纺织股份有限公司 2021-05-28 CN claimed
US-20170283691-A1 QUANTUM DOT-CONTAINING COMPOSITIONS INCLUDING AN EMISSION STABILIZER, PRODUCTS INCLUDING SAME, AND METHOD SAMSUNG ELECTRONICS CO LTD (KR) 2017-10-05 US claimed
US-9701896-B2 Quantum dot-containing compositions including an emission stabilizer, products including same, and method SAMSUNG ELECTRONICS CO., LTD. (KR) 2017-07-11 US claimed
CN-106821933-A A kind of preparation method of composite plant essential oil suncream 济南大学 2017-06-13 CN claimed
US-20150021521-A1 QUANTUM DOT-CONTAINING COMPOSITIONS INCLUDING AN EMISSION STABILIZER, PRODUCTS INCLUDING SAME, AND METHOD QD VISION, INC. (US) 2015-01-22 US claimed
WO-2013078252-A1 QUANTUM DOT-CONTAINING COMPOSITIONS INCLUDING AN EMISSION STABILIZER, PRODUCTS INCLUDING SAME, AND METHOD QD VISION, INC. (US) 2013-05-30 WO claimed
EP-2234675-A1 ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS Schering-Plough Healthcare Products, Inc. (US) 2010-10-06 EP claimed
WO-2009079486-A1 ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) 2009-06-25 WO claimed
US-20090155194-A1 ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. 2009-06-18 US claimed
US-5954844-A BACKING SUPPORTING SURFACE-BOUND ABRASIVE PARTICLES AND ANTILOADING COMPOUND COMPRISING AN ALKYLATED OR FLUOROALKYLATED ORGANOBORON, ORGANONITROGEN, ORGANOPHOSPHORUS, ORGANOSULFUR, OR HYDROXYCARBOXYLIC ACID DERIVATIVE MINNESOTA MINING & MANUFACTURING COMPANY (US) 1999-09-21 US claimed
EP-0912295-A1 ABRASIVE ARTICLE COMPRISING AN ANTILOADING COMPONENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1999-05-06 EP claimed
US-5704952-A COATINGS, BONDING, NONWOVEN ABRASIVES AND BINDERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-01-06 US claimed
WO-1997042007-A1 ABRASIVE ARTICLE COMPRISING AN ANTILOADING COMPONENT MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-11-13 WO claimed
JP-6151161-A None JP disclosed
JP-3227455-A None JP disclosed
US-4169061-A Fiber treating compositions EASTMAN KODAK COMPANY (US) 1979-09-25 US disclosed
US-4039715-A ORGANIC ESTERS, WAXES, PARTIALLY ORIENTED YARN EASTMAN KODAK COMPANY (US) 1977-08-02 US disclosed
US-3951825-A ORGANIC ESTERS EASTMAN KODAK COMPANY (US) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090155194-A1 ENHANCED PHOTOSTABILITY OF AVOBENZONE IN THE PRESENCE OF ZINC OXIDE USING PHOSPHATE-BASED EMULSIFIERS TYR, AP2S1, POLL AGTR1 1874/4885LPAR3 4113/4885LPAR2 4159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.